Wockhardt launches Epox, sees Rs 10-cr sales in 2 yrs
Wockhardt has launched Epox, a recombinant human erythro-protein drug based on biotechnology for treatment of Cancer and Chronic renel failure. "We have made Epox therapy more affordable and this
Wockhardt has launched Epox, a recombinant human erythro-protein drug based on biotechnology for treatment of Cancer and Chronic renel failure. "We have made Epox therapy more affordable and this